A histone deacetylase inhibitor seems to restore the transcriptional activity of a silenced gene by overcoming heterochromatin effects, thereby offering a potential treatment for the neurodegenerative disease Friedreich's ataxia.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A wearable motion capture suit and machine learning predict disease progression in Friedreich’s ataxia
Nature Medicine Open Access 19 January 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Campuzano, V. et al. Science 271, 1423–1427 (1996).
Herman, D. et al. Nat. Chem. Biol. 2, 551–558 (2006).
Dillon, N. & Festenstein, R. Trends Genet. 18, 252–258 (2002).
Muller, H.J. J. Genet. 22, 299–334 (1930).
Milot, E., Fraser, P. & Grosveld, F. Trends Genet. 12, 123–126 (1996).
Saveliev, A., Everett, C., Sharpe, T., Webster, Z. & Festenstein, R. Nature 422, 909–913 (2003).
Reuter, G. & Spierer, P. Bioessays 14, 605–612 (1992).
Festenstein, R. et al. Nat. Genet. 23, 457–461 (1999).
Jenuwein, T. & Allis, C.D. Science 293, 1074–1080 (2001).
Ohshima, K., Montermini, L., Wells, R.D. & Pandolfo, M. J. Biol. Chem. 273, 14588–14595 (1998).
Bidichandani, S.I., Ashizawa, T. & Patel, P.I. Am. J. Hum. Genet. 62, 111–121 (1998).
Gottlicher, M. et al. EMBO J. 20, 6969–6978 (2001).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Festenstein, R. Breaking the silence in Friedreich's ataxia. Nat Chem Biol 2, 512–513 (2006). https://doi.org/10.1038/nchembio1006-512
Issue Date:
DOI: https://doi.org/10.1038/nchembio1006-512